Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D14VOX
|
|||
| Drug Name |
A157
|
|||
| Drug Type |
Fusion protein
|
|||
| Indication | Immune thrombocytopenic purpura [ICD-11: 3B64.13; ICD-10: D69; ICD-9: 287.31] | IND submitted | [1] | |
| Company |
Klus Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thrombopoietin (THPO) | Target Info | Agonist | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Jak-STAT signaling pathway | ||||
| Hematopoietic cell lineage | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Klus Pharma | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.